TNOA Journal of Ophthalmic Science and Research

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 57  |  Issue : 2  |  Page : 109--112

Topical nepafenac in the treatment of center involving diabetic macular edema


TP Vignesh 
 Department of Retina-Vitreous, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India

Correspondence Address:
Dr. T P Vignesh
Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, No. 1, Anna Nagar, Madurai - 625 020, Tamil Nadu
India

Purpose: To assess the efficacy of topical nepafenac 0.1% in the treatment of center-involving diabetic macular edema (DME). Design: A prospective, interventional case series. Methods: Fourteen eyes of thirteen patients with center-involving DME were included in the study, and they were administered topical nepafenac eye drops 0.1% thrice daily, for 6 months. Vision and foveal thickness were recorded at the baseline and 2nd, 4th, and 6th month follow-up visits. Results: The mean baseline and final LogMAR visual acuity were 0.35 and 0.18, respectively, and the mean baseline and final foveal thickness were 463.4 μm and 291.8 μm, respectively, both showing a statistically significant improvement (P < 0.05). Conclusion: Topical nepafenac is effective in the treatment of center-involving DME in this small case series; however, a large randomized study is warranted.


How to cite this article:
Vignesh T P. Topical nepafenac in the treatment of center involving diabetic macular edema.TNOA J Ophthalmic Sci Res 2019;57:109-112


How to cite this URL:
Vignesh T P. Topical nepafenac in the treatment of center involving diabetic macular edema. TNOA J Ophthalmic Sci Res [serial online] 2019 [cited 2019 Sep 16 ];57:109-112
Available from: http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2019;volume=57;issue=2;spage=109;epage=112;aulast=Vignesh;type=0